Screener
Bio-Rad Laboratories BIO Life Science — Gross Profit
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories in its filing.
Tagged under the XBRL concept us-gaap:GrossProfit.
The source filing: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:19 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000012208-26-000035
FAQ
- What is Bio-Rad Laboratories's life science — gross profit?
- Bio-Rad Laboratories (BIO) reported life science — gross profit of $127.6M in Q1 2026.
- How has Bio-Rad Laboratories's life science — gross profit changed year-over-year?
- Bio-Rad Laboratories's life science — gross profit decreased by 0.6% year-over-year, from $128.4M to $127.6M.
- What is the long-term trend for Bio-Rad Laboratories's life science — gross profit?
- Over 3 years (2022 to 2025), Bio-Rad Laboratories's life science — gross profit has grown at a -12.1% compound annual growth rate (CAGR), from $814.5M to $553.1M.
- What does life science — gross profit mean?
- The difference between the Life Science segment's net sales and its cost of goods sold. It represents the profit generated before accounting for operating expenses such as R&D, selling, and administrative costs.
Ask your AI about Bio-Rad Laboratories's life science — gross profit.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude